[1]
P. N. Johnson, PharmD, BCPS, D. Harrison, PhD, and C. Allen, MD, “Utility of transdermal fentanyl for prevention of iatrogenic opioid abstinence syndrome in children”, J of Opioid Management, vol. 6, no. 2, pp. 117–124, Jan. 2018.